Morton Kern, MD, of VA Long Beach Healthcare System and University of California, Irvine, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in ...
A new high-sensitivity blood test for heart attacks successfully diagnosed heart attacks faster and more accurately in the emergency room than the existing test. A new test to assess a whether or not ...
When Marc Hammer went to the emergency room feeling fatigued and dizzy, he had no idea his life was actually at risk. "I'm an avid cyclist and walk five to 15 miles a day," said Hammer, "so you can ...
As a cardiologist, I see this far too often: women come to us later in the course of heart disease, sometimes after weeks or even months of vague symptoms that were dismissed or misdiagnosed. We've ...
A test used by doctors in the emergency room to determine if a person is having a heart attack is now equipped to be more sensitive than ever. In addition to diagnosing heart attacks earlier, the test ...
A saliva test could fast track heart attack diagnosis, according to preliminary research presented today at ESC Congress 2020. The innovative technique requires patients to spit into a tube and ...
Sophia Antipolis, France - 26 Aug 2020: A saliva test could fast track heart attack diagnosis, according to preliminary research presented today at ESC Congress 2020.1 The innovative technique ...
The newer high-sensitivity troponin test discovers smaller amounts of heart-specific proteins, troponins, than the older troponin test and thus identifies more myocardial infarction patients than ...
A fast diagnosis is essential when dealing with a possible heart attack. Typically, emergency room clinicians scan the chest for signs using either an ultrasound or an electrocardiogram, or send away ...
When Marc Hammer went to the emergency room feeling fatigued and dizzy, he had no idea his life was actually at risk. “I’m an avid cyclist and walk five to 15 miles a day,” said Hammer, “so you can ...
ABBOTT PARK, Ill., Sept. 25, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that its ARCHITECT STAT High Sensitivity Troponin-I blood test has received clearance from the U.S. Food and Drug ...
High-sensitivity cardiac troponin assays may eventually play a part in an overall strategy for evaluating patients who present with stable chest pain symptoms and possible coronary disease, an ...